Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LEAP THERAPEUTICS, INC.

(LPTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Leap Therapeutics : Raises $104 Million After Completing Securities Offering; Stock Rises

09/24/2021 | 01:03pm EDT


ę MT Newswires 2021
All news about LEAP THERAPEUTICS, INC.
10/04LEAP THERAPEUTICS : Mizuho Securities Starts Leap Therapeutics at Buy With $6 Price Target
MT
09/24LEAP THERAPEUTICS : Raises $104 Million After Completing Securities Offering; Stock Rises
MT
09/24LEAP THERAPEUTICS : Announces Closing of Public Offering of Common Stock and Pre-Funded Wa..
PU
09/24LEAP THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/24LEAP THERAPEUTICS : Announces Closing of Public Offering of Common Stock and Pre-Funded Wa..
PR
09/22AFTER HOURS WATCH LIST SCORECARD : Sfix, fdx, lptx,
MT
09/22LEAP THERAPEUTICS : Prices $90 Million Offering of Common Shares, Pre-Funded Warrants
MT
09/22LEAP THERAPEUTICS : Announces Pricing of $90 million of Common Stock and Pre-Funded Warran..
PU
09/22LEAP THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financ..
AQ
09/22LEAP THERAPEUTICS : Announces Pricing of $90 million of Common Stock and Pre-Funded Warran..
PR
More news
Analyst Recommendations on LEAP THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 2,74 M - -
Net income 2021 -39,7 M - -
Net Debt 2021 - - -
P/E ratio 2021 -6,17x
Yield 2021 -
Capitalization 253 M 253 M -
Capi. / Sales 2021 92,2x
Capi. / Sales 2022 675x
Nbr of Employees 30
Free-Float 78,8%
Chart LEAP THERAPEUTICS, INC.
Duration : Period :
Leap Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEAP THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,90 $
Average target price 4,80 $
Spread / Average Target 65,5%
EPS Revisions
Managers and Directors
Doug E. Onsi President, CEO, CFO, Secretary & Treasurer
Chris K. Mirabelli Chairman
Cynthia Sirard Chief Medical Officer
Michael Haas Head-Research
Augustine J. Lawlor Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
LEAP THERAPEUTICS, INC.28.89%253
GILEAD SCIENCES, INC.16.15%84 845
BIONTECH SE261.78%71 229
WUXI APPTEC CO., LTD.24.08%64 399
REGENERON PHARMACEUTICALS19.27%59 906
VERTEX PHARMACEUTICALS-21.73%47 992